| RS2148841110 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2148841537 |
MFSD8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2148844303 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2148845188 |
STIL
|
Health Risk |
Likely pathogenic |
— |
| RS2148846582 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular cardiomyopathy, Cardiomyopathy |
| RS2148849959 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148849982 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148850223 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2148850492 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148850505 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148850717 |
SP110
|
Health Risk |
Pathogenic/Likely pathogenic |
Hepatic veno-occlusive disease-immunodeficiency syndrome, Hepatic veno-occlusive disease-immunodeficiency syndrome |
| RS2148850769 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148852029 |
MYT1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2148854716 |
ANKRD17
|
Health Risk |
Likely pathogenic |
Chopra-Amiel-Gordon syndrome, Chopra-Amiel-Gordon syndrome |
| RS2148861371 |
TBC1D23
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia, type 11 |
| RS2148863572 |
TBC1D23
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia, type 11 |
| RS2148864234 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148866261 |
WDFY3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2148866902 |
WDFY3
|
Health Risk |
Pathogenic |
— |
| RS2148873794 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2148874807 |
PTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Basal cell carcinoma |
| RS2148890956 |
MECOM
|
Health Risk |
Likely pathogenic |
Radioulnar synostosis, Radioulnar synostosis |
| RS2148891008 |
MECOM
|
Health Risk |
Pathogenic |
Radioulnar synostosis, Radioulnar synostosis |
| RS2148891037 |
MECOM
|
Health Risk |
Pathogenic |
Radioulnar synostosis, Radioulnar synostosis |
| RS2148891074 |
MECOM
|
Health Risk |
Likely pathogenic |
Radioulnar synostosis, Radioulnar synostosis |
| RS2148894604 |
THRB
|
Health Risk |
Pathogenic |
— |
| RS2148897874 |
SEC23B
|
Health Risk |
Pathogenic |
— |
| RS2148907184 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2148917380 |
SP110
|
Health Risk |
Pathogenic |
Hepatic veno-occlusive disease-immunodeficiency syndrome, Hepatic veno-occlusive disease-immunodeficiency syndrome |
| RS2148922004 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2148924638 |
DEPDC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2148926458 |
SP110
|
Health Risk |
Pathogenic |
Hepatic veno-occlusive disease-immunodeficiency syndrome, Hepatic veno-occlusive disease-immunodeficiency syndrome |
| RS2148942481 |
NLRC4
|
Health Risk |
Conflicting classifications of pathogenicity |
Periodic fever-infantile enterocolitis-autoinflammatory syndrome, Familial cold autoinflammatory syndrome 4 |
| RS2148942588 |
NLRC4
|
Health Risk |
Pathogenic |
Familial cold autoinflammatory syndrome 4, Familial cold autoinflammatory syndrome 4 |
| RS2148943607 |
MFSD8
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2148947240 |
MECOM
|
Health Risk |
Pathogenic |
Radioulnar synostosis with amegakaryocytic thrombocytopenia 2, Radioulnar synostosis with amegakaryocytic thrombocytopenia 2 |
| RS2148949901 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2148951277 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2148952560 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2148952714 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2148953095 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2148953333 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2148953712 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Epilepsy, familial focal |
| RS2148959323 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148959539 |
LIPH
|
Health Risk |
Pathogenic |
Hypotrichosis 7, Hypotrichosis 7 |
| RS2148959744 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148960027 |
MYT1L
|
Health Risk |
Likely pathogenic |
— |
| RS2148960326 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148968418 |
DEPDC5
|
Health Risk |
Pathogenic/Likely pathogenic |
SUDDEN INFANT DEATH SYNDROME, SUDDEN INFANT DEATH SYNDROME |
| RS2148968890 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2148968909 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2148972564 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2148972962 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2148981349 |
MED12L
|
Health Risk |
Conflicting classifications of pathogenicity |
Nizon-Isidor syndrome, Nizon-Isidor syndrome |
| RS2148982295 |
UROD
|
Health Risk |
Likely pathogenic |
— |
| RS2148982720 |
UROD
|
Health Risk |
Pathogenic |
— |
| RS2148982736 |
UROD
|
Health Risk |
Likely pathogenic |
— |
| RS2148982945 |
UROD
|
Health Risk |
Likely pathogenic |
Familial porphyria cutanea tarda, Familial porphyria cutanea tarda |
| RS2148983625 |
UROD
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2148984206 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2148984299 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148984775 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148988855 |
WDFY3
|
Health Risk |
Pathogenic |
— |
| RS2149004143 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149008270 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2149008450 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149009008 |
MFSD8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2149009371 |
DEPDC5
|
Health Risk |
Pathogenic |
— |
| RS2149009589 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149014816 |
DMD
|
Health Risk |
Pathogenic |
Intermediate muscular dystrophy, Intermediate muscular dystrophy |
| RS2149015246 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149015335 |
GJA8
|
Health Risk |
Likely pathogenic |
Developmental cataract, Cataract 1 multiple types |
| RS2149015418 |
GJA8
|
Health Risk |
Pathogenic |
Cataract 1 multiple types, Cataract 1 multiple types |
| RS2149015482 |
GJA8
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 1 multiple types, Cataract 1 multiple types |
| RS2149015516 |
GJA8
|
Health Risk |
Likely pathogenic |
Cataract 1 multiple types, Cataract 1 multiple types |
| RS2149015656 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149015763 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149015783 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149015924 |
GJA8
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental cataract, Cataract 1 multiple types |
| RS2149016192 |
MYT1L
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Intellectual disability |
| RS2149017828 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2149017839 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2149017840 |
MAGT1
|
Health Risk |
Likely pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2149017933 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149018065 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149018213 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149018217 |
MAGT1
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2149018402 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149018410 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2149018425 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2149018434 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2149018666 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149024046 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149024566 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149024925 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149025148 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149031468 |
MAGT1
|
Health Risk |
Likely pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2149033494 |
EXOSC9
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia, type 1D |
| RS2149039042 |
ITGA6
|
Health Risk |
Pathogenic |
Epidermolysis bullosa, junctional 6 |
| RS2149039114 |
EXOSC9
|
Health Risk |
Pathogenic |
— |